Exane Derivatives’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-782
Closed -$61.2K 1058
2021
Q2
$61.2K Buy
782
+778
+19,450% +$59.3K 0.01% 621
2021
Q1
$272 Sell
4
-65
-94% -$5.11K ﹤0.01% 847
2020
Q4
$4.81K Sell
69
-830
-92% -$51.6K ﹤0.01% 562
2020
Q3
$46.2K Hold
899
0.01% 377
2020
Q2
$52.7K Sell
899
-2,624
-74% -$145K 0.01% 348
2020
Q1
$178K Sell
3,523
-2,533
-42% -$168K 0.05% 212
2019
Q4
$430K Buy
+6,056
New +$378K 0.08% 188
2019
Q2
Sell
-1
Closed -$74 686
2019
Q1
$74 Sell
1
-217
-100% -$15.3K ﹤0.01% 589
2018
Q4
$13K Hold
218
﹤0.01% 450
2018
Q3
$20.7K Buy
218
+1
+0.5% +$86 ﹤0.01% 415
2018
Q2
$16.6K Sell
217
-4,574
-95% -$329K ﹤0.01% 439
2018
Q1
$288K Buy
4,791
+109
+2% +$5.9K 0.06% 213
2017
Q4
$218K Buy
4,682
+2,060
+79% +$102K 0.04% 233
2017
Q3
$133K Sell
2,622
-29
-1% -$1.35K 0.02% 226
2017
Q2
$132K Buy
+2,651
New +$124K 0.03% 241

Other funds holding HQY

Exane Derivatives's HQY Position: Q3 2021 in Review

Exane Derivatives sold out of HealthEquity (HQY) in Q3 2021, closing a stake of 782 shares — an estimated $61.2K sold.

Exane Derivatives first reported a position in HQY in Q2 2017 and held it in 15 quarters. The position peaked at $430K in Q4 2019. 286 funds tracked by Wall St. Rank hold HQY as of Q3 2021.

  • Exane Derivatives reported no remaining HealthEquity position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 782 HealthEquity shares in Q3 2021, an estimated $61.2K.
  • Exane Derivatives first reported a position in HealthEquity in Q2 2017 and held it in 15 quarters.
  • Exane Derivatives's HealthEquity position peaked at $430K in Q4 2019.
  • 286 funds tracked by Wall St. Rank held HealthEquity as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.